SEC Info - AbbVie Inc. - ‘8-K’ for 4/26/24

SEC Info℠

Home

Help

Please Sign In

AbbVie Inc. – ‘8-K’ for 4/26/24

On: Friday, 4/26/24, at 7:43am ET · For: 4/26/24 · Accession #: 1551152-24-16 · File #: 1-35565

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/26/24  AbbVie Inc.                       8-K:2,9     4/26/24   12:553K

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     43K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    259K 
 7: R1          Document and Entity Information Document            HTML     69K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- abbv-20240426_htm                   XML     36K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      9K 
 4: EX-101.DEF  XBRL Definitions -- abbv-20240426_def                XML     52K 
 5: EX-101.LAB  XBRL Labels -- abbv-20240426_lab                     XML    104K 
 6: EX-101.PRE  XBRL Presentations -- abbv-20240426_pre              XML     52K 
 3: EX-101.SCH  XBRL Schema -- abbv-20240426                         XSD     16K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               17±    25K 
11: ZIP         XBRL Zipped Folder -- 0001551152-24-000016-xbrl      Zip     43K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

abbv-20240426

i 0001551152 i false00015511522024-04-262024-04-260001551152us-gaap:CommonStockMemberexch:XNYS2024-04-262024-04-260001551152exch:XCHIus-gaap:CommonStockMember2024-04-262024-04-260001551152abbv:Sec1.375SeniorNotesDue2024Memberexch:XNYS2024-04-262024-04-260001551152exch:XNYSabbv:Sec1250SeniorNotesDue2024Member2024-04-262024-04-260001551152exch:XNYSabbv:Sec0.750SeniorNotesDue2027Member2024-04-262024-04-260001551152abbv:Sec2.125SeniorNotesdue2028Memberexch:XNYS2024-04-262024-04-260001551152abbv:Sec2625SeniorNotesDue2028Memberexch:XNYS2024-04-262024-04-260001551152exch:XNYSabbv:Sec2125SeniorNotesDue2029Member2024-04-262024-04-260001551152abbv:Sec1.250SeniorNotesdue2031Memberexch:XNYS2024-04-262024-04-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________________________

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i April 26, 2024

i ABBVIE INC.

(Exact name of registrant as specified in its charter)

i Delaware

i 001-35565

i 32-0375147

(State or other Jurisdiction

(Commission File Number)

(IRS Employer

of Incorporation)

Identification No.)

_____________________________________________________

i 1 North Waukegan Road

i North Chicago, i Illinois i 60064-6400

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: ( i 847) i 932-7900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

i i Common Stock, $0.01 Par Value /

i i ABBV /

i New York Stock Exchange

i Chicago Stock Exchange

i 1.375% Senior Notes due 2024

i ABBV24

i New York Stock Exchange

i 1.250% Senior Notes due 2024

i ABBV24B

i New York Stock Exchange

i 0.750% Senior Notes due 2027

i ABBV27

i New York Stock Exchange

i 2.125% Senior Notes due 2028

i ABBV28

i New York Stock Exchange

i 2.625% Senior Notes due 2028

i ABBV28B

i New York Stock Exchange

i 2.125% Senior Notes due 2029

i ABBV29

i New York Stock Exchange

i 1.250% Senior Notes due 2031

i ABBV31

i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On April 26, 2024, AbbVie Inc. issued a press release announcing financial results for the first quarter ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits


Exhibit No.						Exhibit
99.1						Press Release dated April 2 6 , 202 4 (furnished pursuant to Item 2.02).
104						The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			ABBVIE INC.

Date:	April 26, 2024	By:	/s/ *Scott T. Reents*
			Scott T. Reents
			Executive Vice President,
			Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	4/26/24
	3/31/24	4
		List all Filings

↑Top

Filing Submission 0001551152-24-000016 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

AbbVie Inc. – ‘8-K’ for 4/26/24

On: Friday, 4/26/24, at 7:43am ET · For: 4/26/24 · Accession #: 1551152-24-16 · File #: 1-35565

Previous ‘8-K’: ‘8-K’ on / for 4/3/24 · Latest ‘8-K’: This Filing

Current Report — Form 8-KFiling Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Current Report — Form 8-K

Filing Table of Contents